Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
6.83
+0.01 (0.15%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Viemed Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 224.26 | 183.01 | 138.83 | 117.06 | 131.31 | Upgrade
|
| Revenue Growth (YoY) | 22.54% | 31.82% | 18.60% | -10.85% | 63.61% | Upgrade
|
| Cost of Revenue | 91.05 | 70.23 | 54.15 | 43.65 | 51.2 | Upgrade
|
| Gross Profit | 133.2 | 112.78 | 84.68 | 73.41 | 80.11 | Upgrade
|
| Selling, General & Admin | 105.85 | 87.35 | 68.16 | 54.89 | 52.83 | Upgrade
|
| Research & Development | 3.07 | 2.78 | 2.7 | 2.11 | 1.08 | Upgrade
|
| Other Operating Expenses | -0.73 | -0.1 | -0.99 | -0.12 | -0.45 | Upgrade
|
| Operating Expenses | 115.95 | 97.27 | 76.08 | 62.88 | 59.16 | Upgrade
|
| Operating Income | 17.25 | 15.51 | 8.6 | 10.53 | 20.95 | Upgrade
|
| Interest Expense | -0.78 | -0.42 | -0.2 | -0.32 | -0.51 | Upgrade
|
| Interest & Investment Income | - | 0.49 | 0.94 | - | - | Upgrade
|
| Earnings From Equity Investments | - | - | - | 1.24 | 0.09 | Upgrade
|
| EBT Excluding Unusual Items | 16.47 | 15.57 | 9.34 | 11.45 | 20.54 | Upgrade
|
| Merger & Restructuring Charges | -0.35 | -0.54 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.95 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.91 | -0.65 | -0.35 | -0.45 | 2.33 | Upgrade
|
| Other Unusual Items | -0.9 | - | - | 1.5 | 3.5 | Upgrade
|
| Pretax Income | 16.17 | 14.39 | 8.99 | 12.5 | 26.36 | Upgrade
|
| Income Tax Expense | 4.76 | 4.15 | 2.77 | 3.38 | -5.17 | Upgrade
|
| Earnings From Continuing Operations | 11.41 | 10.24 | 6.22 | 9.13 | 31.53 | Upgrade
|
| Minority Interest in Earnings | -0.14 | - | - | - | - | Upgrade
|
| Net Income | 11.27 | 10.24 | 6.22 | 9.13 | 31.53 | Upgrade
|
| Net Income to Common | 11.27 | 10.24 | 6.22 | 9.13 | 31.53 | Upgrade
|
| Net Income Growth | 9.98% | 64.63% | -31.82% | -71.06% | 269.85% | Upgrade
|
| Shares Outstanding (Basic) | 39 | 38 | 39 | 39 | 39 | Upgrade
|
| Shares Outstanding (Diluted) | 41 | 40 | 40 | 41 | 41 | Upgrade
|
| Shares Change (YoY) | 1.05% | 1.44% | -2.15% | 0.38% | 1.96% | Upgrade
|
| EPS (Basic) | 0.29 | 0.27 | 0.16 | 0.23 | 0.81 | Upgrade
|
| EPS (Diluted) | 0.28 | 0.25 | 0.16 | 0.22 | 0.78 | Upgrade
|
| EPS Growth | 12.00% | 56.25% | -27.27% | -71.80% | 271.43% | Upgrade
|
| Free Cash Flow | 1.32 | 19.12 | 4.85 | 2.75 | 22.07 | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.47 | 0.12 | 0.07 | 0.54 | Upgrade
|
| Gross Margin | 59.40% | 61.63% | 60.99% | 62.71% | 61.01% | Upgrade
|
| Operating Margin | 7.69% | 8.48% | 6.19% | 8.99% | 15.96% | Upgrade
|
| Profit Margin | 5.02% | 5.60% | 4.48% | 7.80% | 24.01% | Upgrade
|
| Free Cash Flow Margin | 0.59% | 10.45% | 3.49% | 2.35% | 16.80% | Upgrade
|
| EBITDA | 42.62 | 37.38 | 24.23 | 21.84 | 30.54 | Upgrade
|
| EBITDA Margin | 19.00% | 20.42% | 17.45% | 18.66% | 23.25% | Upgrade
|
| D&A For EBITDA | 25.37 | 21.86 | 15.63 | 11.31 | 9.58 | Upgrade
|
| EBIT | 17.25 | 15.51 | 8.6 | 10.53 | 20.95 | Upgrade
|
| EBIT Margin | 7.69% | 8.48% | 6.19% | 8.99% | 15.96% | Upgrade
|
| Effective Tax Rate | 29.44% | 28.82% | 30.79% | 27.01% | - | Upgrade
|
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.